D. Lynn Kirkpatrick

2007 - Oncothyreon

In 2007, D. Lynn Kirkpatrick earned a total compensation of $351.4K as Chief Scientific Officer at Oncothyreon, a 553% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$63,500
Option Awards$29,845
Salary$250,000
Other$8,046
Total$351,391

Kirkpatrick received $250K in salary, accounting for 71% of the total pay in 2007.

Kirkpatrick also received $63.5K in non-equity incentive plan, $29.8K in option awards and $8K in other compensation.

Rankings

In 2007, D. Lynn Kirkpatrick's compensation ranked 7,071st out of 8,700 executives tracked by ExecPay. In other words, Kirkpatrick earned more than 18.7% of executives.

ClassificationRankingPercentile
All
7,071
out of 8,700
19th
Division
Services
1,058
out of 1,256
16th
Major group
Engineering, Accounting, Research, Management, And Related Services
99
out of 121
18th
Industry group
Research, Development, And Testing Services
38
out of 48
21st
Industry
Commercial Physical and Biological Research
33
out of 42
21st
Source: SEC filing on April 29, 2008.

Kirkpatrick's colleagues

We found six more compensation records of executives who worked with D. Lynn Kirkpatrick at Oncothyreon in 2007.

2007

Robert Kirkman

Oncothyreon

Chief Executive Officer

2007

Edward Taylor

Oncothyreon

Chief Financial Officer

2007

Marilyn Olson

Oncothyreon

Vice President, Clinical Regulatory Affairs

2007

Robert Aubrey

Oncothyreon

Former Vice President, Business Development

2007

Gary Christianson

Oncothyreon

Chief Operating Officer

2007

R Koganty

Oncothyreon

Vice President and General Manager Synthetic Biologics Business Unit

News

You may also like